Toronto Dominion Bank
OLMA icon

Toronto Dominion Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Toronto Dominion Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Buy
+1
New +$13 ﹤0.01% 2266

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Toronto Dominion Bank's OLMA Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 1 share worth $13. The stake represents ﹤0.01% of the portfolio and ranks #2266 among its holdings.

185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Toronto Dominion Bank held 1 share of Olema Pharmaceuticals worth $13 as of Q2 2026.
  • Olema Pharmaceuticals was a new Toronto Dominion Bank position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2266 holding.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.